2 Clarke Drive
Cranbury, NJ 08512
© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
American Oncology Network, LLC, a high-growth medical oncology provider with a focus on supporting the long-term viability of oncology treatment in community-based settings is pleased to announce that Stephen “Fred” Divers, MD has been named as the company’s new Chief Medical Officer.
“We are thrilled to announce Dr. Divers as our Chief Medical Officer,” said Todd Schonherz, AON Chief Executive Officer. “Since AON’s inception and as Chairman of the AON Advisory Board, Dr. Divers has been instrumental in leading the charge on ensuring patients have ready access to affordable, high quality cancer care in their local communities. The depth of his involvement in clinical research and patient advocacy is commendable and he will undoubtedly make a great impact in this executive leadership role.”
“AON and its practices are uniquely positioned to serve cancer patients with convenient and affordable quality cancer care,” said Dr. Divers. “I look forward to continuing to contribute to future successes and innovations in this newly-created leadership role.”
Dr. Divers is a Medical Oncologist with Genesis Cancer and Blood Institute, one of the first practices to join the AON network in the summer of 2018. In July of 2020, he was named Advisory Board Chairman. Dr. Divers has provided physician leadership as a member of several national committees and currently serves on the Board of Directors for the Community Oncology Alliance (COA). He attended medical school at the Louisiana State University School of Medicine. He completed his residency at the University of North Carolina and a fellowship at the University of Alabama at Birmingham Cancer Center.
In addition to his new role as CMO, Dr. Divers will continue as AON Advisory Board Chairman and see patients at Genesis Cancer and Blood Institute.